The given sequence checksum does not match our current record for P18507!
P18507 (GBRG2_HUMAN) Homo sapiens (Human)
Gamma-aminobutyric acid receptor subunit gamma-2 UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
27 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Complex of GABA-A synaptic receptor with autoimmune antibody Fab175 |
Heteromer P14867; P47870; | 3×NAG; 2×NAG; 1×NAG; 2×ABU; 2×NAG; 1×MAN; | ||||
| Assess | ||||||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus allopregnanolone |
Heteromer P14867; P47870; | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×Y4B; 2×ABU; | ||||
| Assess | ||||||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus pregnenolone sulfate |
Heteromer P14867; P47870; | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 6×PTY; 1×Q3G; 1×A8W; | ||||
| Assess | ||||||
| Complex of GABA-A synaptic receptor with autoimmune antibody Fab115 |
Heteromer P14867; P47870; | 4×NAG; 2×NAG; 1×NAG; | ||||
| Assess | ||||||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus etomidate |
Heteromer P14867; P47870; | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 2×V8D; | ||||
| Assess | ||||||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus dehydroepiandrosterone s… |
Heteromer P14867; P47870; | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 1×ZWY; 6×PTY; 1×Q3G; 1×POV; | ||||
| Assess | ||||||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus propofol |
Heteromer P14867; P47870; | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 2×PFL; | ||||
| Assess | ||||||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus picrotoxin |
Heteromer P14867; P47870; | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 1×RI5; | ||||
| Assess | ||||||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus diazepam |
Heteromer P14867; P47870; | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 4×DZP; | ||||
| Assess | ||||||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with bicuculline methbromide |
Heteromer P14867; P47870; | 2×NAG; 1×NAG; 1×NAG; 3×NAG; 2×J94; 1×MAN; | ||||
| Assess | ||||||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA |
Heteromer P14867; P47870; | 2×NAG; 1×NAG; 1×NAG; 3×NAG; 2×ABU; | ||||
| Assess | ||||||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus phenobarbital |
Heteromer P14867; P47870; | 2×NAG; 1×NAG; 1×NAG; 3×NAG; 2×ABU; 2×UQA; | ||||
| Assess | ||||||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus flumazenil |
Heteromer P14867; P47870; | 2×NAG; 1×NAG; 1×NAG; 3×NAG; 2×ABU; 1×FYP; | ||||
| Assess | ||||||
| CryoEM structure of human full-length alpha1beta3gamma2L GABA(A)R in complex with picrotoxin and me… |
Heteromer P08219; P28472; | 1×NAG; 3×NAG; 2×NAG; 1×NAG; 2×PIO; 1×RI5; | ||||
| Assess | ||||||
| CryoEM structure of human full-length alpha1beta3gamma2L GABA(A)R in complex with bicuculline and m… |
Heteromer P08219; P28472; | 1×NAG; 3×NAG; 2×NAG; 1×NAG; 2×H0Z; 2×PIO; | ||||
| Assess | ||||||
| CryoEM structure of human full-length heteromeric alpha1beta3gamma2L GABA(A)R in complex with alpra… |
Heteromer P08219; P28472; | 1×NAG; 3×NAG; 2×NAG; 1×NAG; 2×ABU; 2×PIO; 1×08H; | ||||
| Assess | ||||||
| CryoEM structure of human full-length alpha1beta3gamma2L GABA(A)R in complex with diazepam (Valium)… |
Heteromer P14867; P28472; | 1×NAG; 3×NAG; 2×NAG; 1×NAG; 2×PIO; 2×ABU; 3×DZP; | ||||
| Assess | ||||||
| CryoEM structure of human full-length heteromeric alpha1beta3gamma2L GABA(A)R in complex with picro… |
Heteromer P08219; P28472; | 1×NAG; 2×NAG; 3×NAG; 1×NAG; 2×PIO; 1×RI5; 2×ABU; | ||||
| Assess | ||||||
| Cryo-EM structure of human full-length synaptic alpha1beta3gamma2 GABA(A)R in complex with Ro15-451… |
Heteromer P14867; P28472; | 1×NAG; 2×NAG; 2×NAG; 1×NAG; 2×PIO; 1×OCT; 4×D10; 3×CL; 1×NAG; 1×EIE; | ||||
| Assess | ||||||
| Cryo-EM structure of the human synaptic alpha1-beta3-gamma2 GABAA receptor in complex with Megabody… |
Heteromer P14867; P28472; | 2×NAG; 3×NAG; 1×NAG; 1×NAG; 3×POV; 2×PIO; | ||||
| Assess | ||||||
| Cryo-EM structure of human full-length beta3gamma2 GABA(A)R in complex with GABA and nanobody Nb25 |
Heteromer P28472; | 3×NAG; 3×NAG; 2×NAG; 1×ABU; | ||||
| Assess | ||||||
| Human GABA-A receptor alpha1-beta2-gamma2 subtype in complex with GABA and flumazenil, conformation… |
Heteromer P14867; P47870; | 2×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 12×Y01; 1×FYP; | ||||
| Assess | ||||||
| GABA-A receptor a5 heteromer - a5V2 - Bretazenil |
Heteromer P31644; | 5×QMU; 5×DMU; 3×NO3; 6×NAG; | ||||
| Assess | ||||||
| Cryo-EM structure of human full-length alpha4beta3gamma2 GABA(A)R in complex with GABA and nanobody… |
Heteromer P28472; P48169; | 4×NAG; 3×NAG; 2×NAG; 1×ABU; | ||||
| Assess | ||||||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus Zolpidem |
Heteromer P14867; P47870; | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 3×R5R; 2×ABU; | ||||
| Assess | ||||||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus DMCM |
Heteromer P14867; P47870; | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 3×R63; | ||||
| Assess | ||||||
| Human GABA-A receptor alpha1-beta2-gamma2 subtype in complex with GABA and flumazenil, conformation… |
Heteromer P14867; P47870; | 2×NAG; 1×NAG; 1×NAG; 3×NAG; 2×ABU; 12×Y01; 1×FYP; | ||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6hug.1.C | monomer | 0.72 | 1×NAG; | 100.00 | ||
| Assess | ||||||
3 SWISS-MODEL models built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 1 | 6hug.1.C | monomer | 0.72 | 100.00 | ||
| Assess | ||||||
| Isoform 3 | 6hug.1.C | monomer | 0.65 | 1×NAG; | 99.79 | |
| Assess | ||||||
| Isoform 3 | 3uq7.1.A | monomer | 0.52 | 19.71 | ||
| Assess | ||||||